Skip to content
Home / How We Deliver / Facilities Network

Facilities Network

CordenPharma is the CDMO partner you need for the reliable supply of complex modalities along your drug development lifecycle. Harnessing the collective expertise of teams across our globally-integrated cGMP facility network, we provide bespoke outsourcing services spanning the complete supply chain of APIs, drug products and lipid excipients from early clinical-phase development to commercialization.

With 11 cGMP facilities across Europe and North America, our small to large-scale manufacturing capacities and technologies are strategically focused on peptides, oligonucleotides, customized lipid excipients, lipid nanoparticles (LNPs), sterile injectables, and the extensive supply of small molecules (both highly potent and regular potency).

Bergamo, Italy

Bergamo, Italy

Bergamo, Italy

Luca Porcu, Managing Director

Corden Pharma Bergamo S.p.A.
Via Bergamo 121
24047 Treviglio (Bergamo)
Italy

See on Google Maps

APIs

Research & Development
Research & Development
GMP Manufacturing
GMP Manufacturing
Phase III
Phase III
Regulatory Approval
Regulatory Approval
Commercialization APIs
Commercialization APIs
API Support Services
API Support Services

Technology Platforms

Small Molecules
Small Molecules
Caponago, Italy

Caponago, Italy

Caponago, Italy

Giuseppe Martelli, Managing Director

Corden Pharma S.p.A.
Viale dell’Industria, 3
20867 Caponago
Monza Brianza
Italy

See on Google Maps

Drug Products

Research & Development
Research & Development
GMP Manufacturing
GMP Manufacturing
Phase I-II
Phase I-II
Phase III
Phase III
LNP Formulation
LNP Formulation
Regulatory Approval
Regulatory Approval
Commercialization Drug Products
Commercialization Drug Products
Drug Product Support Services
Drug Product Support Services

Technology Platforms

Injectables
Injectables
Chenôve, France

Chenôve, France

Chenôve, France

Dr. James Leresche, Managing Director

Corden Pharma Chenôve SAS
47, rue de Longvic
B.P. 50
21301 Chenôve Cedex
France

See on Google Maps

APIs

Research & Development
Research & Development
GMP Manufacturing
GMP Manufacturing
Phase I-II
Phase I-II
Phase III
Phase III
Regulatory Approval
Regulatory Approval
Commercialization APIs
Commercialization APIs
API Support Services
API Support Services

Lipid Excipients

Research & Development
Research & Development
Preclinical
Preclinical
GMP Manufacturing
GMP Manufacturing
Phase I - II
Phase I - II
Phase III
Phase III
Regulatory Approval
Regulatory Approval
Commercialization Lipid Excipients
Commercialization Lipid Excipients
API Support Services
API Support Services

Technology Platforms

Lipids & Carbohydrates
Lipids & Carbohydrates
Small Molecules
Small Molecules
Colorado (Boulder), US

Colorado (Boulder), US

Colorado (Boulder), US

Craig Dixon, Managing Director

Corden Pharma Colorado
2075 55th Street
Boulder
80301

See on Google Maps

APIs

Research & Development
Research & Development
GMP Manufacturing
GMP Manufacturing
Phase I-II
Phase I-II
Phase III
Phase III
Regulatory Approval
Regulatory Approval
Commercialization APIs
Commercialization APIs
API Support Services
API Support Services

Technology Platforms

Peptides
Peptides
Oligonucleotides
Oligonucleotides
Highly Potent & Oncology
Highly Potent & Oncology
Small Molecules
Small Molecules
Ettingen, Switzerland

Ettingen, Switzerland

Ettingen, Switzerland

Yvan Liard, Managing Director

Patrick Wolff, Site Head

Corden Pharma Fribourg AG, Zweigniederlassung Ettingen
Brühlstrasse 50
P.O.Box / 4107 Ettingen
Switzerland

See on Google Maps

Drug Products

Research & Development
Research & Development
GMP Manufacturing
GMP Manufacturing
Phase I-II
Phase I-II
Phase III
Phase III
LNP Formulation
LNP Formulation
Regulatory Approval
Regulatory Approval
Commercialization Drug Products
Commercialization Drug Products
Drug Product Support Services
Drug Product Support Services

Technology Platforms

Small Molecules
Small Molecules
Frankfurt, Germany

Frankfurt, Germany

Frankfurt, Germany

Dr. Karsten Meyenberg, Head of Operations

Corden Pharma International GmbH (Frankfurt)
Gebäude C26
Alt-Fechenheim 34
60386 Frankfurt am Main
Germany

See on Google Maps

APIs

Research & Development
Research & Development
Preclinical
Preclinical
GMP Manufacturing
GMP Manufacturing
Phase I-II
Phase I-II
Regulatory Approval
Regulatory Approval
API Support Services
API Support Services

Technology Platforms

Peptides
Peptides
Fribourg, Switzerland

Fribourg, Switzerland

Fribourg, Switzerland

Yvan Liard, Managing Director

Corden Pharma Fribourg SA
Route de Moncor 10
1752 Villars-sur-Glâne
Switzerland

See on Google Maps

Drug Products

Research & Development
Research & Development
GMP Manufacturing
GMP Manufacturing
Phase I-II
Phase I-II
Phase III
Phase III
Regulatory Approval
Regulatory Approval
Commercialization Drug Products
Commercialization Drug Products
Drug Product Support Services
Drug Product Support Services

Technology Platforms

Small Molecules
Small Molecules
Liestal, Switzerland

Liestal, Switzerland

Liestal, Switzerland

Dr. Thomas Müller, Managing Director

Corden Pharma Switzerland LLC
Eichenweg 1
4410 Liestal
Switzerland

See on Google Maps

APIs

Research & Development
Research & Development
Preclinical
Preclinical
GMP Manufacturing
GMP Manufacturing
Phase I-II
Phase I-II
Phase III
Phase III
Regulatory Approval
Regulatory Approval
Commercialization APIs
Commercialization APIs
API Support Services
API Support Services

Lipid Excipients

Discovery
Discovery
Research & Development
Research & Development
Preclinical
Preclinical
GMP Manufacturing
GMP Manufacturing
Phase I - II
Phase I - II
Phase III
Phase III
Regulatory Approval
Regulatory Approval
Commercialization Lipid Excipients
Commercialization Lipid Excipients
API Support Services
API Support Services

Technology Platforms

Lipids & Carbohydrates
Lipids & Carbohydrates
Small Molecules
Small Molecules
Lisbon, Portugal

Lisbon, Portugal

Lisbon, Portugal

Rosário Fonseca, Managing Director

Corden Pharma Lisbon S.A.
R. da Indústria, 2
Quinta Grande
2610-088 Amadora
(Apartado 60 001 · 2701-951 Amadora)
Lisboa, Portugal

See on Google Maps

Drug Products

GMP Manufacturing
GMP Manufacturing
Phase III
Phase III
Regulatory Approval
Regulatory Approval
Commercialization Drug Products
Commercialization Drug Products
Drug Product Support Services
Drug Product Support Services

Technology Platforms

Small Molecules
Small Molecules
Plankstadt, Germany

Plankstadt, Germany

Plankstadt, Germany

Dr. Lutz Henkel, Geschäftsführer

Corden Pharma GmbH
Otto-Hahn-Strasse
68723 Plankstadt
Germany

VAT ID: DE271759255
Register court: Mannheim, HRB 709385

See on Google Maps

Drug Products

Research & Development
Research & Development
Preclinical
Preclinical
GMP Manufacturing
GMP Manufacturing
Phase I-II
Phase I-II
Phase III
Phase III
Regulatory Approval
Regulatory Approval
Commercialization Drug Products
Commercialization Drug Products
Drug Product Support Services
Drug Product Support Services

Technology Platforms

Highly Potent & Oncology
Highly Potent & Oncology
Small Molecules
Small Molecules

Want to find out more?

Get in touch with our team of experts to explore bespoke end-to-end CDMO support of your complete drug lifecycle
at any scale.